| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases
|
Shimada, Kazuyo
|
|
2019
|
84 |
5 |
p. 1097-1105
|
artikel
|
| 2 |
A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients
|
Tani, Tetsuo
|
|
2019
|
84 |
5 |
p. 1065-1071
|
artikel
|
| 3 |
A phase I study evaluating combined nimotuzumab and neoadjuvant chemoradiotherapy followed by surgery in locally advanced esophageal cancer
|
Qi, Saichun
|
|
2019
|
84 |
5 |
p. 1115-1123
|
artikel
|
| 4 |
A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies
|
Lynce, Filipa
|
|
2019
|
84 |
5 |
p. 1145-1151
|
artikel
|
| 5 |
Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice
|
Hughes, Jim H.
|
|
2019
|
84 |
5 |
p. 1073-1087
|
artikel
|
| 6 |
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer
|
Shimada, Midori
|
|
2019
|
84 |
5 |
p. 1059-1064
|
artikel
|
| 7 |
Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment
|
Sun, Yanan
|
|
2019
|
84 |
5 |
p. 1133-1143
|
artikel
|
| 8 |
Evaluation of the potential for QTc prolongation with avelumab
|
Vugmeyster, Yulia
|
|
2019
|
84 |
5 |
p. 1017-1026
|
artikel
|
| 9 |
Exposure–response analysis to inform the optimal dose of veliparib in combination with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer patients
|
Nuthalapati, Silpa
|
|
2019
|
84 |
5 |
p. 977-986
|
artikel
|
| 10 |
Italian survey on cetuximab-based therapy of elderly patients with metastatic colorectal cancer
|
Rosati, Gerardo
|
|
2019
|
84 |
5 |
p. 1089-1096
|
artikel
|
| 11 |
Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma
|
Yamada, Yuto
|
|
2019
|
84 |
5 |
p. 987-992
|
artikel
|
| 12 |
Pharmacokinetics and safety of neratinib during co-administration with loperamide in healthy subjects
|
Keyvanjah, Kiana
|
|
2019
|
84 |
5 |
p. 1125-1132
|
artikel
|
| 13 |
Phase I trial of pimasertib monotherapy in Japanese patients with solid tumors and those with hepatocellular carcinoma
|
Yamazaki, K.
|
|
|
84 |
5 |
p. 1027-1037
|
artikel
|
| 14 |
Phase I trial of pimasertib monotherapy in Japanese patients with solid tumors and those with hepatocellular carcinoma
|
Yamazaki, K.
|
|
2019
|
84 |
5 |
p. 1027-1037
|
artikel
|
| 15 |
Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: a systematic review
|
Kulma, Inthuorn
|
|
2019
|
84 |
5 |
p. 959-975
|
artikel
|
| 16 |
Population pharmacokinetics and exposure–overall survival analysis of the transforming growth factor-β inhibitor galunisertib in patients with pancreatic cancer
|
Gueorguieva, Ivelina
|
|
2019
|
84 |
5 |
p. 1003-1015
|
artikel
|
| 17 |
Population pharmacokinetics of siltuximab: impact of disease state
|
Nikanjam, Mina
|
|
2019
|
84 |
5 |
p. 993-1001
|
artikel
|
| 18 |
Prodrugs as drug delivery system in oncology
|
Delahousse, J.
|
|
2019
|
84 |
5 |
p. 937-958
|
artikel
|
| 19 |
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study
|
Sakurada, Takumi
|
|
2019
|
84 |
5 |
p. 1107-1114
|
artikel
|
| 20 |
Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan
|
Yunokawa, Mayu
|
|
2019
|
84 |
5 |
p. 1051-1058
|
artikel
|
| 21 |
Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab
|
Liu, Baoquan
|
|
2019
|
84 |
5 |
p. 1039-1049
|
artikel
|
| 22 |
The thioredoxin system and cancer therapy: a review
|
Mohammadi, Fariba
|
|
2019
|
84 |
5 |
p. 925-935
|
artikel
|
Tijdschrift beschrijving